ES2093494T3 - Fracciones de heparina purificadas, procedimiento de obtencion y composiciones farmaceuticas que los contienen. - Google Patents

Fracciones de heparina purificadas, procedimiento de obtencion y composiciones farmaceuticas que los contienen.

Info

Publication number
ES2093494T3
ES2093494T3 ES94400994T ES94400994T ES2093494T3 ES 2093494 T3 ES2093494 T3 ES 2093494T3 ES 94400994 T ES94400994 T ES 94400994T ES 94400994 T ES94400994 T ES 94400994T ES 2093494 T3 ES2093494 T3 ES 2093494T3
Authority
ES
Spain
Prior art keywords
contain
pharmaceutical compositions
heparin fractions
obtaining procedure
purified heparin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94400994T
Other languages
English (en)
Inventor
Jean-Francois Branellec
Jose Espejo
Philippe Picart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Choay SA
Original Assignee
Choay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9446915&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2093494(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Choay SA filed Critical Choay SA
Application granted granted Critical
Publication of ES2093494T3 publication Critical patent/ES2093494T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

FRACCIONES DE HEPARINA OBTENIDAS POR DEPOLIMERIZACION NITROSA, QUE CONTIENE A LO SUMO 150 PPB DE COMPUESTOS NITROSADOS TOTALES, PREPARADOS SOMETIENDO HEPARINAS DEPOLIMERIZADAS POR UN NITRITO A LA ACCION DE LA RADIACION UV.
ES94400994T 1993-05-07 1994-05-06 Fracciones de heparina purificadas, procedimiento de obtencion y composiciones farmaceuticas que los contienen. Expired - Lifetime ES2093494T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9305534A FR2704861B1 (fr) 1993-05-07 1993-05-07 Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.

Publications (1)

Publication Number Publication Date
ES2093494T3 true ES2093494T3 (es) 1996-12-16

Family

ID=9446915

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94400994T Expired - Lifetime ES2093494T3 (es) 1993-05-07 1994-05-06 Fracciones de heparina purificadas, procedimiento de obtencion y composiciones farmaceuticas que los contienen.

Country Status (26)

Country Link
US (1) US5599801A (es)
EP (1) EP0623629B1 (es)
JP (1) JP3529835B2 (es)
KR (1) KR100328095B1 (es)
CN (1) CN1066155C (es)
AT (1) ATE141618T1 (es)
AU (1) AU672291B2 (es)
BR (1) BR9401920A (es)
CA (1) CA2122930C (es)
CZ (1) CZ287889B6 (es)
DE (1) DE69400385T2 (es)
DK (1) DK0623629T3 (es)
ES (1) ES2093494T3 (es)
FI (1) FI107388B (es)
FR (1) FR2704861B1 (es)
GR (1) GR3021648T3 (es)
HK (1) HK1007432A1 (es)
HU (1) HU221595B (es)
IL (1) IL109587A (es)
MY (1) MY110862A (es)
NO (1) NO306952B1 (es)
NZ (1) NZ260460A (es)
PL (1) PL178294B1 (es)
RU (1) RU2133253C1 (es)
TW (1) TW438812B (es)
ZA (1) ZA943152B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5980865A (en) * 1995-08-18 1999-11-09 Baker Norton Pharmaceuticals, Inc. Method for treating late phase allergic reactions and inflammatory diseases
CA2235223A1 (en) 1995-10-30 1997-05-09 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase i
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
IT1290814B1 (it) * 1997-03-24 1998-12-11 Istituto Scient Di Chimica E B Glicosaminoglicani aventi elevata attivita' antitrombotica
JP2003527822A (ja) * 1998-08-27 2003-09-24 マサチューセッツ インスティテュート オブ テクノロジー ヘパリナーゼｉおよびｉｉ由来の合理的に設計されたヘパリナーゼ
US7056504B1 (en) 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
CA2643162C (en) * 1999-04-23 2018-01-02 Massachusetts Institute Of Technology Polymer identification, compositional analysis and sequencing, based on property comparison
CA2402160C (en) * 2000-03-08 2012-02-14 Massachusetts Institute Of Technology Heparinase iii and uses thereof
US8227449B2 (en) * 2000-03-30 2012-07-24 Glycores 2000 S.R.L. Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
IT1318432B1 (it) * 2000-03-30 2003-08-25 Inalco Spa Glicosaminoglicani derivati dal polisaccaride k5 aventi elevataattivita' anticoagulante ed antitrombotica e processo per la loro
ATE426805T1 (de) * 2000-09-12 2009-04-15 Massachusetts Inst Technology Verfahren und produkte, die mit niedermolekularem heparin assoziiert sind
CA2423469A1 (en) * 2000-10-18 2002-04-25 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
US20050027117A1 (en) * 2000-12-18 2005-02-03 Pasqua Oreste Anticoagulant and antithrombotic LMW-glycosaminoglycans derived from K5 polysaccharide and process for their preparation
JP2002293804A (ja) * 2001-03-28 2002-10-09 Itoham Foods Inc 低分子量ヘパリンの製造法
EP2402753A1 (en) 2002-03-11 2012-01-04 Momenta Pharmaceuticals, Inc. Analysis of sulfated polysaccharides
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
ITMO20040199A1 (it) * 2004-07-29 2004-10-29 Biofer Spa Procedimento per la purificazione da gruppi e n no rsidui di eparine a basso peso molecolare ottentite tramite nitrosazione.
JP2006291028A (ja) * 2005-04-11 2006-10-26 Q P Corp 低分子ヘパリンまたはその塩、ならびにその製造方法
EP1792621B1 (en) 2005-11-30 2012-04-04 Istituto di Ricerche Chimiche e Biochimiche "G. Ronzoni" Orally administrable heparin derivatives
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
ES2817779T3 (es) * 2010-01-19 2021-04-08 Momenta Pharmaceuticals Inc Evaluación de preparaciones de heparina
CA2811186C (en) * 2010-09-14 2018-12-04 Michio Muguruma High purity heparin and production method therefor
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CN102633905B (zh) * 2011-04-11 2014-10-08 南通天龙畜产品有限公司 一种肝素钠中不被亚硝酸降解且在肝素钠保留时间附近出峰的物质的去除方法
CN104045744B (zh) * 2014-06-26 2016-01-06 常州千红生化制药股份有限公司 达肝素钠的制备方法
CN104098716B (zh) * 2014-07-16 2015-04-22 南京健友生化制药股份有限公司 一种达肝素钠精品的生产方法
US10688249B2 (en) * 2015-06-11 2020-06-23 Virchow Biotech Pvt. Ltd. Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same
CN105294885A (zh) * 2015-11-23 2016-02-03 山东大学 一种新来源亚硝酸降解低分子肝素的制备方法
EP3740513B1 (en) * 2018-02-14 2022-06-22 Biological E Limited Improved process for the preparation of dalteparin sodium
RU186728U1 (ru) * 2018-10-19 2019-01-30 Федеральное государственное бюджетное образовательное учреждение высшего образования "МИРЭА - Российский технологический университет" Лабораторное устройство для отмывки порошковых продуктов химических реакций от посторонних примесей
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
CN114616340A (zh) 2019-07-09 2022-06-10 奥普蒂姆维亚有限公司 合成抗凝血多糖的方法
CN110845641A (zh) * 2019-11-07 2020-02-28 中国药科大学 一种肝素寡糖及其在制备抗血管生成药物中的应用
CN110787489A (zh) * 2019-11-20 2020-02-14 江苏千牧生物科技股份有限公司 一种肝素钠加工使用的分离装置及加工的工艺
CN115304688A (zh) * 2022-08-25 2022-11-08 湖北亿诺瑞生物制药有限公司 一种达肝素钠的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2478646A2 (fr) * 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
US4438261A (en) * 1980-05-19 1984-03-20 Riker Laboratories, Inc. Anticoagulant substance
US4351938A (en) * 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
FR2503714B1 (fr) * 1981-04-10 1986-11-21 Choay Sa Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
US5094815A (en) * 1988-05-18 1992-03-10 Cornell Research Foundation, Inc. Photolytic interface for HPLC-chemiluminescence detection of non volatile N-nitroso compounds
US5032679A (en) * 1988-12-15 1991-07-16 Glycomed, Inc. Heparin fragments as inhibitors of smooth muscle cell proliferation
IT1243300B (it) * 1990-12-20 1994-05-26 Fidia Spa Derivati dell'eparina
US5385937A (en) * 1991-04-10 1995-01-31 Brigham & Women's Hospital Nitrosation of homocysteine as a method for treating homocysteinemia

Also Published As

Publication number Publication date
HK1007432A1 (en) 1999-04-09
MY110862A (en) 1999-05-31
IL109587A (en) 1997-04-15
TW438812B (en) 2001-06-07
NO941686D0 (no) 1994-05-06
HU9401446D0 (en) 1994-08-29
AU672291B2 (en) 1996-09-26
CN1096034A (zh) 1994-12-07
IL109587A0 (en) 1994-08-26
CZ287889B6 (cs) 2001-03-14
EP0623629A1 (fr) 1994-11-09
FR2704861A1 (fr) 1994-11-10
HUT70553A (en) 1995-10-30
EP0623629B1 (fr) 1996-08-21
ZA943152B (en) 1995-01-09
FI942095A0 (fi) 1994-05-06
CA2122930A1 (en) 1994-11-08
ATE141618T1 (de) 1996-09-15
RU2133253C1 (ru) 1999-07-20
RU94015595A (ru) 1996-09-27
CA2122930C (en) 2000-10-24
PL178294B1 (pl) 2000-04-28
US5599801A (en) 1997-02-04
JP3529835B2 (ja) 2004-05-24
JPH07126302A (ja) 1995-05-16
AU6191294A (en) 1994-11-10
DE69400385D1 (de) 1996-09-26
DK0623629T3 (da) 1996-12-23
GR3021648T3 (en) 1997-02-28
CZ113294A3 (en) 1994-12-15
NO306952B1 (no) 2000-01-17
CN1066155C (zh) 2001-05-23
NO941686L (no) 1994-11-08
BR9401920A (pt) 1994-11-29
DE69400385T2 (de) 1996-12-19
FR2704861B1 (fr) 1995-07-28
NZ260460A (en) 1996-02-27
FI942095A (fi) 1994-11-08
KR100328095B1 (ko) 2002-06-20
HU221595B (hu) 2002-11-28
FI107388B (fi) 2001-07-31

Similar Documents

Publication Publication Date Title
ES2093494T3 (es) Fracciones de heparina purificadas, procedimiento de obtencion y composiciones farmaceuticas que los contienen.
PT91553A (pt) Processo de preparacao de uma composicao contendo morfina
DK0386997T3 (da) Anvendelse af 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater i behandlingen af psykose, inflammation og som immunosuppressive midler
ES2081458T3 (es) Composicion de pintura.
BR9504234A (pt) Fibra de polímero termoplástica pigmentada composiçao de pigmento estabilizado e processo para sua preparaçao
ES2088675T3 (es) Un metodo para unir articulos y un par de articulos sujetos por el metodo.
MX9102582A (es) Derivados de indol 3,7-disubstituidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
BR8804367A (pt) Um composto de triazina substituida por arilenodiamino,um processo para fabricar o dito composto,uma composicao resistente a degradacao e um artigo de borracha resistente ao ozonio feito empregando o dito composto
PT98481A (pt) Processo para a preparacao de clatratos de peroxiacidos
BR9200425A (pt) Processo para producao de uma pelicula contraida,pelicula contraida,laminados de pelicula contraida e uso da referida pelicula
IT1269961B (it) Processo per la produzione di derivati orto-isopropil-fenoli
ITMI931019A0 (it) Derivati del cicloeptimmidazolo, metodo per la loro produzione e agenti terapeutici contenenti questi composti
BR9101397A (pt) Composicao de resina termoplastica,processo para estabilizar uma resina termoplastica,e processo para melhorar as propriedades mecanicas de uma resina de poliolefina modificada
ES2104295T3 (es) Derivados ciclopeptidicos de la angiopeptina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATA252892A (de) Benzofuranylimidazolderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
ITMI930421A0 (it) Derivati del benzofurano e loro uso come stabilizzanti verso le radiazioni uv
ITMI912767A0 (it) Processo per la dealogenazione di derivati del naftalene
FI933386A0 (fi) Laogmolekylaera sulfaterade poly-b-2,6-fruktofuranosaner och deras anvaendning vid behandling av degenerativa ledsjukdomar
ES2093912T3 (es) Procedimiento para la depuracion de 1,1-dicloro-1-fluoroetano.
BR9200569A (pt) Composicao de resina curavel,verniz,laminado e processo para preparar um laminado
BR8303293A (pt) Composicao sinergica para a protecao da madeira,emprego e processo para o tratamento de madeira
IT8222807A0 (it) Derivati 2,3- sostituiti di idrocarburi bicicli e processo per la loro preparazione.
JPS52135344A (en) Synthetic resins
SE9201309D0 (sv) Apparat foer destruktion av smaa avfallsobjekt, saasom injektionssprutor, kanyler eller liknande

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 623629

Country of ref document: ES